Jenburkt Pharma - Quaterly Results

05 Nov 2024 Evaluate
The revenue zoomed 7.64% to Rs. 412.16 millions for the quarter ended September 2024 as compared to Rs. 382.89 millions during the corresponding quarter last year.Net Profit recorded in the quarter ended September 2024 rise to 31.14% to Rs. 96.02  millions  compared to R. 73.22 millions in corresponding previous quarter.Operating profit surged to 132.79 millions from the corresponding previous quarter of 102.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 412.16 382.89 7.64 737.52 674.64 9.32 1419.66 1367.49 3.82
Other Income 18.53 10.96 69.07 32.59 21.33 52.79 46.67 51.23 -8.90
PBIDT 132.79 102.00 30.19 239.73 182.04 31.69 377.85 354.90 6.47
Interest 1.16 0.69 68.12 2.31 1.43 61.54 2.71 3.67 -26.16
PBDT 131.63 101.31 29.93 237.42 180.61 31.45 375.14 351.23 6.81
Depreciation 6.39 5.91 8.12 11.58 10.91 6.14 23.40 22.59 3.59
PBT 125.24 95.40 31.28 225.84 169.70 33.08 351.74 328.64 7.03
TAX 29.22 22.18 31.74 55.67 42.79 30.10 91.98 82.58 11.38
Deferred Tax -0.78 -3.48 -77.59 0.67 -2.89 -123.18 -5.21 -2.25 131.56
PAT 96.02 73.22 31.14 170.17 126.91 34.09 259.76 246.06 5.57
Equity 44.13 44.13 0.00 44.13 44.13 0.00 44.13 44.13 0.00
PBIDTM(%) 32.22 26.64 20.94 32.50 26.98 20.46 26.62 25.95 2.55

Jenburkt Pharma Share Price

1020.45 8.75 (0.86%)
01-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1696.95
Dr. Reddys Lab 1152.40
Cipla 1444.55
Lupin 1956.40
Zydus Lifesciences 877.50
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...